Whitepaper: Cubis® II Pharma Compliant by Design
Posted: 2 April 2019 | Sartorius | No comments yet
Sartorius’ Cubis® II balance series offers customisable modularity to ensure compliance with FDA directive 21 CFR Part II and EU Annex 11. This whitepaper outlines details of the technical solutions that will enable companies to achieve full compliance.
The Cubis® II balance series was designed for customisable modularity, which means the user can choose from many hardware and software options for thousands of different configurations. Choose from among 45 weighing modules, seven draft shields, two display and control units, and five software packages, including more than 60 software apps.
Related content from this organisation
- Quality from the start: designing a scalable AAV production platform
- European Pharmaceutical Review Issue 4 2024
- Application note: Equivalency of PCR-based rapid sterility testing and the compendial culture method
- Product hub: Choosing the right tool for method screening and process optimisation
- Microbial fermentation tech market to exceed $56.9b by 2033
